England’s Innovative Medicines Fund Picks Up Pace As Alexion’s Kanuma Gets Green Light

 
• By Eliza Slawther

Alexion has secured funding for its Wolman disease drug Kanuma via England’s Innovative Medicines Fund after several years of “constructive collaboration” with the country’s health technology assessment body NICE and the National Health Service.

Traffic light on green
• Source: Shutterstock

More from Rare Diseases

More from Pink Sheet